Home›Stock Screener›Roopa Industries

Roopa Industries Share Price Today | Stock Price & Roopa Industries Share Screener

ROOPAIND Pharmaceuticals & Biotechnology
Live Share Price BSE
₹42.05
▼ -1.45 (-3.33%)
2026-11-18 00:00:00

As of November 18, 2026, the live Roopa Industries share price (BSE: ROOPAIND) is ₹42.05, down 3.33% from the previous close, with shares trading between ₹42.00 and ₹45.00 in today's trading session, and a 52-week range of ₹39.19–₹60.48. Track ROOPAIND market capitalization to gauge the company's total market size. Use the Roopa Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Roopa Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Roopa Industries Market Cap ₹33.10 Cr.
ROOPAIND P/E Ratio (TTM) 269.50
Roopa Industries P/B Ratio 1.93
EPS (TTM) ₹0.13
Dividend Yield -
Debt to Equity 1.83
ROOPAIND 52 Week High ₹60.48
Roopa Industries 52 Week Low ₹39.19
Operating Margin 3.00%
Profit Margin -
ROOPAIND Revenue (TTM) ₹131.00
EBITDA ₹4.00
Net Income -
Total Assets ₹72.00
Total Equity ₹18.00

Roopa Industries Share Price Chart

Track the current stock price of Roopa Industries with an interactive chart. Analyse ROOPAIND share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Roopa Industries stock quote in one place.

The quote of ₹42.05 sits between the 52-week low of ₹39.19 and the 52-week high of ₹60.48, and the latest session moved -3.33% from the previous close.

Roopa Industries Company Profile - Fundamental Screener

Screen Roopa Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ROOPAIND shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE443C01010.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE443C01010

Roopa Industries Balance Sheet Screener

Screen ROOPAIND balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹72, down from ₹77 in 2025.

Latest statistics put total assets at ₹72 and shareholder funds at ₹18, with a leverage ratio of 1.83.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 72 77 65 57 49 46 38 37 35 29
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 8 8 9 10 10 10 11 6 6 7

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 4 8 7 3 5 9 9 10 11 8
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 18 18 16 14 13 12 11 10 10 9
Share Capital 8 8 8 8 8 8 8 8 8 8
Reserves & Surplus 10 10 8 6 5 4 3 3 2 2

Roopa Industries Income Statement Screener - Profit & Revenue Analysis

Screen Roopa Industries income statement and profit fundamentals. Analyze ROOPAIND quarterly results. Roopa Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹131 and net profit was ₹0, equal to earnings per unit of ₹0.10, at an operating margin of 3%.

In that period expenses were ₹127, interest cost ₹3 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹128 and net profit of ₹0.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 131 128 123 72 77 51 29 29 30 24 30 34 31
Expenses 127 119 117 66 72 48 26 26 28 22 28 32 29

Operating Costs and Margins

EBITDA 4 8 6 6 5 4 3 3 3 2 3 2 2
Operating Profit % 3.00% 6.00% 3.00% 6.00% 5.00% 7.00% 9.00% 6.00% 8.00% -14.00% 7.00% -3.00% 7.00%
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Interest 3 3 3 3 2 1 1 1 1 1 2 2 1

Profit and Earnings

Profit Before Tax 0 0 3 2 2 1 1 1 1 0 0 0 0
Tax 0 0 1 1 1 0 0 0 0 0 0 0 0
Net Profit 0 0 2 2 1 1 1 0 1 1 0 0 0
EPS 0.10 0.13 2.57 1.95 1.72 1.30 0.98 0.48 0.77 0.69 0.00 0.22 0.20

Roopa Industries Cash Flow Screener - Liquidity Fundamentals

Screen ROOPAIND cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹5, and net cash flow was an outflow of ₹3.

Over the same period, investing activities used ₹1 and financing activities used ₹8.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 5 -7 2 0 2 -1 2 4 -5 -1
Investing Activities -1 2 1 -1 4 1 1 -2 3 0

Financing and Net Cash

Financing Activities -8 5 -2 2 -5 -1 -3 -2 2 2
Net Cash Flow -3 0 1 0 1 0 0 0 0 0

Roopa Industries Shareholding Pattern Screener

See Roopa Industries shareholding pattern with promoter, FII, and DII holdings. Check Roopa Industries promoter holding and ownership changes for ROOPAIND on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 48.03%, foreign institutions 0.25%, domestic institutions 0.00% and the public 41.00%, spread across 3,954 shareholders.

The shareholder count was 3,954 in 2026-Mar, compared with 3,888 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 48.03% 48.03% 48.03% 48.03% 48.03% 48.03% 48.03% 48.03%

Institutional Investors

FII Holding 0.25% 0.25% 0.25% 0.25% 0.25% 0.25% 0.25% 0.25%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 41.00% 41.00% 40.96% 40.85% 40.95% 40.87% 40.92% 40.63%
Other Holding 10.72% 10.72% 10.75% 10.86% 10.76% 10.85% 10.80% 11.09%
Shareholder Count 3,954 3,888 3,894 4,007 4,002 3,982 3,952 3,622

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Roopa Industries. Roopa Industries dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Roopa Industries.

Roopa Industries Stock Index Membership - Nifty & Sensex

See which indices include Roopa Industries stock. Check ROOPAIND index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Roopa Industries is not part of any tracked indices.
Only major market indices are tracked in our system.

Roopa Industries Market Events Screener - Corporate Actions

Get Roopa Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Roopa Industries stock events that may affect ROOPAIND share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Annual General Meeting dated September 30, 2026 and Quarterly Result Announcement dated August 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA -1.21%
2026-09-30 2026-09-30 Annual General Meeting NA -6.25%
2026-08-14 2026-08-14 Quarterly Result Announcement NA 1.83%
2026-05-30 2026-05-30 Quarterly Result Announcement NA -4.47%
2026-02-14 2026-02-14 Quarterly Result Announcement NA -0.54%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -0.20%
2025-09-30 2025-09-30 Annual General Meeting NA -1.87%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -4.67%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -5.64%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -7.94%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -5.55%
2024-09-30 2024-09-30 Annual General Meeting NA -1.81%

Roopa Industries Competitors Screener - Peer Stocks Comparison

Screen ROOPAIND competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,700 41.10 61,674 12.69% 11,565 63.60
Divis Laboratories 291,153 90.70 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 177,499 84.50 13,886 20.34% 2,138 47.27
Laurus Labs 119,728 98.10 6,868 22.01% 890 69.60
Zydus Life Science 118,563 27.60 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 114,994 41.70 35,059 3.90% 4,158 70.24
Cipla 112,414 39.40 29,045 2.24% 3,870 54.92
Mankind Pharma 108,164 48.40 14,636 14.85% 1,938 65.43
Aurobindo Pharma 103,977 26.40 34,145 5.56% 3,503 66.06
Lupin 89,839 17.30 29,039 26.75% 5,356 44.92

Roopa Industries Company Announcements - News & Reports Screener

Screen ROOPAIND latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 18, 2026.

The next most recent announcements are dated November 18, 2026 and November 11, 2026.

Date Update Actions
2026-11-18 Submission Of Unaudited Financial Results And Intimation Of Outcome Of The Board Meeting Held On 14Th November 2026 -
2026-11-18 Board Meeting Outcome for Submission Of Unaudited Financial Results And Intimation Of Outcome Of The Board Meeting Held On 14Th November 2026 -
2026-11-11 Board Meeting Intimation for Intimation Regarding Board Meeting To Be Held On Saturday 14Th November 2026 To Consider And Approve The Unaudited Financial Results For The Half Year And Quarter Ended On 30Th September 2026 -
2026-10-12 Report On Re-Lodgement Of Transfer Requests Of Physical Shares Under Special Window -
2026-10-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-25 Closure of Trading Window -
2026-09-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-05 Reg. 34 (1) Annual Report. -
2026-09-05 Intimation Of Annual General Meeting For The FY 2025-26 -
2026-09-01 Outcome Of Board Meeting Held On 1St September 2026 -
2026-08-18 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-14 Submission Of Unaudited Financial Results -
2026-08-14 Board Meeting Outcome for Submission Of Unaudited Financial Results And Intimation Of Outcome Of The Board Meeting Held On 14Th August 2026 -
2026-08-11 Submission Of Report On Re-Lodgement Of Transfer Requests Of Physical Shares Under Special Window -
2026-08-11 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-07 Board Meeting Intimation for Intimation Regarding Board Meeting To Be Held On Friday 14Th August 2026 To Consider And Approve The Unaudited Financial Results For The Quarter Ended On 30Th June 2026 -
2026-07-23 Submission Of Report On Re-Lodgement Of Transfer Requests Of Physical Shares Under Special Window -
2026-07-11 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹42.05, within a 52-week range of ₹39.19 to ₹60.48. The P/E ratio is 269.50 and the P/B ratio is 1.93, with earnings per unit of ₹0.13. Market capitalisation stands at ₹33.10 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.